FERRETTI, Carlo
FERRETTI, Carlo
SCIENZA E TECNOLOGIA DEL FARMACO
4-Hydroxynonenal and PPARgamma ligands affect proliferation, differentiation, and apoptosis in colon cancer cells
2007-01-01 CERBONE A; TOALDO C; LAURORA S; BRIATORE F; PIZZIMENTI S; DIANZANI MU; FERRETTI C; BARRERA G
4-hydroxynonenal specifically inhibits c-myb but does not affect c-fos expressions in HL-60 cells.
1996-01-01 BARRERA G; PIZZIMENTI S; SERRA A; FERRETTI C; FAZIO VM; SAGLIO G; DIANZANI MU
4-Hydroxynonenal, a lipid peroxidation product of dietary polyunsaturated fatty acids, has anticarcinogenic properties in colon carcinoma cell lines through the inhibition of telomerase activity
2010-01-01 Pizzimenti S; Menegatti E; Berardi D; Toaldo C; Pettazzoni P; Minelli R; Giglioni B; Cerbone A; Dianzani MU; Ferretti C; Barrera G
A NEW CLASS OF FUROXAN DERIVATIVES AS NO DONORS - MECHANISM OF ACTION AND BIOLOGICAL-ACTIVITY
1995-01-01 FERIOLI R; FOLCO GC; FERRETTI C; GASCO AM; MEDANA C; FRUTTERO R; CIVELLI M; GASCO A
Are the catecholestrogens involved in estrogen-induced striatal dopamine receptor supersensitivity?
1989-01-01 Ferretti, C.; Ghi, P.; Blengio, M.; Gaietta, G.; Barrera, G.; Genazzani, E.
AS601245, an anti-inflammatory JNK inhibitor, and clofibrate have a synergistic effect in inducing cell responses and in affecting the gene expression profile, in CaCo-2 colon cancer cells.
2012-01-01 Angelo Cerbone; Cristina Toaldo; Stefania Pizzimenti; Piergiorgio Pettazzoni; Chiara Dianzani; Rosalba Minelli; Eric Ciamporcero; Guglielmo Roma; Mario Umberto Dianzani; Roberto Canaparo; Carlo Ferretti; and Giuseppina Barrera
AS601245, an Anti-Inflammatory JNK Inhibitor, Strengthens the Effects of Clofibrate and Affects Gene Expression Profile, in CaCo-2 Colon Cancer Cells
2010-01-01 Barrera G; Cerbone A; Toaldo C; Pizzimenti S; Pettazzoni P; Dianzani C; Minelli R; Roma G; Dianzani MU; Ferretti C
Biochemical and behaviour changes induced by acute stress in a chronic variate stress model of depression: the effect of amitriptyline
1995-01-01 FERRETTI C; BLENGIO M; RICCI GAMALERO S; P. GHI
Calmodulin antagonism and growth-inhibiting activity of triphenylethylene antiestrogens in MCF-7 human breast cancer cells.
1986-01-01 GULINO A ;BARRERA G ;VACCA A ;FARINA A ;FERRETTI C ;SCREPANTI I ;DIANZANI MU ;FRATI L
Calmodulin antagonism by antiestrogens in breast cancer cells.
1988-01-01 A. Gulino; G. Barrera; A. Vacca; A. Farina; C. Ferretti; I. Screpanti; M.U. Dianzani ; L. Frati.
Catecolamine ed AMP ciclico nelle sindromi demenziali
1983-01-01 BERGAMASCO B; PINESSI L; PORTALEONE P; FERRERO P; FERRETTI C; BIANCO C; SCARZELLA L; BENNA P; RAINERO I; TARENZI L
Challangers and Opportunities of Nanoparticle-Based Theranostics in Skin Cancer
2016-01-01 Pizzimenti, S.; Dianzani, C.; Zara, G.P.; Ferretti, C.; Rossi, F.; Gigliotti, C.L.; Daga, M.; Cianporcero, E.S.; Maina, G.; Barrera, G.
Changes of rat hippocampal egr-1 expression during the acquisition and retrieval memory phases
2004-01-01 Casale F.; Ghi P.; Orsetti C.; Ferretti C
Cholinergic modulation of Early Growth Response Factor (Egr-1) expression on human neuroblastoma Sk-N-BE cells
2007-01-01 Casale Federico; Carlo Ferretti
Correlation between dental pulp pain, blood levels of ACTH, cortisol and beta-endorphin and the analgesic efficacy of acetylsalicylic acid
1987-01-01 DI GARZEGNA AD ;CASSARINO G ;FERRETTI C ;RAINERO I ;RE G ;VEGLIA M ;PORTALEONE P
Donor CYP3A5 genotype influences tacrolimus disposition on the first day after paediatric liver transplantation
2017-01-01 Calvo, Pier Luigi; Serpe, Loredana; Brunati, Andrea; Nonnato, Antonello; Bongioanni, Daniela; Olio, Dominic Dell'; Pinon, Michele; Ferretti, Carlo; Tandoi, Francesco; Carbonaro, Giulia; Salizzoni, Mauro; Amoroso, Antonio; Romagnoli, Renato; Canaparo, Roberto
Evidences of 4-hydroxynonenal involvement in modulation of phagocyte activities
1995-01-01 DI MAURO C; CAVALLI G; CURZIO M; C. FERRETTI; MENGOZZI G; ROSSI MA; PARADISI L; DIANZANI MU
Furoxans as Nitric Oxide Donors. 4-Phenyl-3-furoxancarbonitrile: Thiol-Mediated Nitric Oxide Release and Biological Evaluation
1994-01-01 C. MEDANA; G. ERMONDI; R. FRUTTERO; A. DI STILO; C. FERRETTI; A. GASCO
GSH-responsive nanoparticles in the treatment of tumor cells.
2015-01-01 Pizzimenti, Stefania; Daga, Martina; Ullio, Chiara; Dianzani, Chiara; Cavalli, Roberta; Trotta, Francesco; Zara, Gian Paolo; Ferretti, Carlo; Gigliotti, Casimiro L.; Ciamporcero, Eric S.; Barrera, Giuseppina .
GSH-targeted nanosponges increase doxorubicin-induced toxicity "in vitro" and "in vivo" in cancer cells with high antioxidant defenses
2016-01-01 Daga, Martina; Ullio, Chiara; Argenziano, Monica; Dianzani, Chiara; Cavalli, Roberta; Trotta, Francesco; Ferretti, Carlo; Zara, Gian Paolo; Gigliotti, Casimiro L.; Ciamporcero, Eric S.; Pettazzoni, Piergiorgio; Corti, Denise; Pizzimenti, Stefania; Barrera, Giuseppina
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 4-Hydroxynonenal and PPARgamma ligands affect proliferation, differentiation, and apoptosis in colon cancer cells | 2007 | CERBONE A; TOALDO C; LAURORA S; BRIATORE F; PIZZIMENTI S; DIANZANI MU; FERRETTI C; BARRERA G | |
| 4-hydroxynonenal specifically inhibits c-myb but does not affect c-fos expressions in HL-60 cells. | 1996 | BARRERA G; PIZZIMENTI S; SERRA A; FERRETTI C; FAZIO VM; SAGLIO G; DIANZANI MU | |
| 4-Hydroxynonenal, a lipid peroxidation product of dietary polyunsaturated fatty acids, has anticarcinogenic properties in colon carcinoma cell lines through the inhibition of telomerase activity | 2010 | Pizzimenti S; Menegatti E; Berardi D; Toaldo C; Pettazzoni P; Minelli R; Giglioni B; Cerbone A; Dianzani MU; Ferretti C; Barrera G | |
| A NEW CLASS OF FUROXAN DERIVATIVES AS NO DONORS - MECHANISM OF ACTION AND BIOLOGICAL-ACTIVITY | 1995 | FERIOLI R; FOLCO GC; FERRETTI C; GASCO AM; MEDANA C; FRUTTERO R; CIVELLI M; GASCO A | |
| Are the catecholestrogens involved in estrogen-induced striatal dopamine receptor supersensitivity? | 1989 | Ferretti, C.; Ghi, P.; Blengio, M.; Gaietta, G.; Barrera, G.; Genazzani, E. | |
| AS601245, an anti-inflammatory JNK inhibitor, and clofibrate have a synergistic effect in inducing cell responses and in affecting the gene expression profile, in CaCo-2 colon cancer cells. | 2012 | Angelo Cerbone; Cristina Toaldo; Stefania Pizzimenti; Piergiorgio Pettazzoni; Chiara Dianzani; Rosalba Minelli; Eric Ciamporcero; Guglielmo Roma; Mario Umberto Dianzani; Roberto Canaparo; Carlo Ferretti; and Giuseppina Barrera | |
| AS601245, an Anti-Inflammatory JNK Inhibitor, Strengthens the Effects of Clofibrate and Affects Gene Expression Profile, in CaCo-2 Colon Cancer Cells | 2010 | Barrera G; Cerbone A; Toaldo C; Pizzimenti S; Pettazzoni P; Dianzani C; Minelli R; Roma G; Dianzani MU; Ferretti C | |
| Biochemical and behaviour changes induced by acute stress in a chronic variate stress model of depression: the effect of amitriptyline | 1995 | FERRETTI C; BLENGIO M; RICCI GAMALERO S; P. GHI | |
| Calmodulin antagonism and growth-inhibiting activity of triphenylethylene antiestrogens in MCF-7 human breast cancer cells. | 1986 | GULINO A ;BARRERA G ;VACCA A ;FARINA A ;FERRETTI C ;SCREPANTI I ;DIANZANI MU ;FRATI L | |
| Calmodulin antagonism by antiestrogens in breast cancer cells. | 1988 | A. Gulino; G. Barrera; A. Vacca; A. Farina; C. Ferretti; I. Screpanti; M.U. Dianzani ; L. Frati. | |
| Catecolamine ed AMP ciclico nelle sindromi demenziali | 1983 | BERGAMASCO B; PINESSI L; PORTALEONE P; FERRERO P; FERRETTI C; BIANCO C; SCARZELLA L; BENNA P; RAINERO I; TARENZI L | |
| Challangers and Opportunities of Nanoparticle-Based Theranostics in Skin Cancer | 2016 | Pizzimenti, S.; Dianzani, C.; Zara, G.P.; Ferretti, C.; Rossi, F.; Gigliotti, C.L.; Daga, M.; Cianporcero, E.S.; Maina, G.; Barrera, G. | |
| Changes of rat hippocampal egr-1 expression during the acquisition and retrieval memory phases | 2004 | Casale F.; Ghi P.; Orsetti C.; Ferretti C | |
| Cholinergic modulation of Early Growth Response Factor (Egr-1) expression on human neuroblastoma Sk-N-BE cells | 2007 | Casale Federico; Carlo Ferretti | |
| Correlation between dental pulp pain, blood levels of ACTH, cortisol and beta-endorphin and the analgesic efficacy of acetylsalicylic acid | 1987 | DI GARZEGNA AD ;CASSARINO G ;FERRETTI C ;RAINERO I ;RE G ;VEGLIA M ;PORTALEONE P | |
| Donor CYP3A5 genotype influences tacrolimus disposition on the first day after paediatric liver transplantation | 2017 | Calvo, Pier Luigi; Serpe, Loredana; Brunati, Andrea; Nonnato, Antonello; Bongioanni, Daniela; Olio, Dominic Dell'; Pinon, Michele; Ferretti, Carlo; Tandoi, Francesco; Carbonaro, Giulia; Salizzoni, Mauro; Amoroso, Antonio; Romagnoli, Renato; Canaparo, Roberto | |
| Evidences of 4-hydroxynonenal involvement in modulation of phagocyte activities | 1995 | DI MAURO C; CAVALLI G; CURZIO M; C. FERRETTI; MENGOZZI G; ROSSI MA; PARADISI L; DIANZANI MU | |
| Furoxans as Nitric Oxide Donors. 4-Phenyl-3-furoxancarbonitrile: Thiol-Mediated Nitric Oxide Release and Biological Evaluation | 1994 | C. MEDANA; G. ERMONDI; R. FRUTTERO; A. DI STILO; C. FERRETTI; A. GASCO | |
| GSH-responsive nanoparticles in the treatment of tumor cells. | 2015 | Pizzimenti, Stefania; Daga, Martina; Ullio, Chiara; Dianzani, Chiara; Cavalli, Roberta; Trotta, Francesco; Zara, Gian Paolo; Ferretti, Carlo; Gigliotti, Casimiro L.; Ciamporcero, Eric S.; Barrera, Giuseppina . | |
| GSH-targeted nanosponges increase doxorubicin-induced toxicity "in vitro" and "in vivo" in cancer cells with high antioxidant defenses | 2016 | Daga, Martina; Ullio, Chiara; Argenziano, Monica; Dianzani, Chiara; Cavalli, Roberta; Trotta, Francesco; Ferretti, Carlo; Zara, Gian Paolo; Gigliotti, Casimiro L.; Ciamporcero, Eric S.; Pettazzoni, Piergiorgio; Corti, Denise; Pizzimenti, Stefania; Barrera, Giuseppina |